COLL logo

Collegium Pharmaceutical (COLL) Current Liabilities

Annual Current Liabilities

$457.92 M
+$24.19 M+5.58%

December 31, 2023


Summary


Performance

COLL Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOLLbalance sheetmetrics:

Quarterly Current Liabilities

$459.43 M
-$2.29 M-0.50%

September 30, 2024


Summary


Performance

COLL Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOLLbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

COLL Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.6%-1.1%
3 y3 years+91.2%-1.1%
5 y5 years+142.1%-1.1%

COLL Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+63.8%-1.1%+64.3%
5 y5-yearat high+127.0%-1.1%+127.7%
alltimeall timeat high>+9999.0%-1.1%+7322.1%

Collegium Pharmaceutical Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$459.43 M(-0.5%)
Jun 2024
-
$461.72 M(+3.4%)
Mar 2024
-
$446.44 M(-2.5%)
Dec 2023
$457.92 M(+5.6%)
$457.92 M(-1.4%)
Sep 2023
-
$464.61 M(+6.8%)
Jun 2023
-
$435.06 M(+5.4%)
Mar 2023
-
$412.70 M(-4.8%)
Dec 2022
$433.73 M(+55.1%)
$433.73 M(+4.6%)
Sep 2022
-
$414.50 M(-0.1%)
Jun 2022
-
$415.09 M(+11.1%)
Mar 2022
-
$373.57 M(+33.6%)
Dec 2021
$279.57 M(+16.8%)
$279.57 M(+3.9%)
Sep 2021
-
$268.97 M(+18.6%)
Jun 2021
-
$226.84 M(-1.4%)
Mar 2021
-
$230.17 M(-3.9%)
Dec 2020
$239.45 M(+18.7%)
$239.45 M(-1.2%)
Sep 2020
-
$242.44 M(-3.8%)
Jun 2020
-
$252.11 M(+3.2%)
Mar 2020
-
$244.37 M(+21.1%)
Dec 2019
$201.76 M
$201.76 M(+0.1%)
DateAnnualQuarterly
Sep 2019
-
$201.48 M(+2.7%)
Jun 2019
-
$196.27 M(+3.9%)
Mar 2019
-
$188.88 M(-0.1%)
Dec 2018
$189.13 M(+500.6%)
$189.13 M(-32.5%)
Sep 2018
-
$280.22 M(+5.9%)
Jun 2018
-
$264.70 M(+5.8%)
Mar 2018
-
$250.23 M(+694.7%)
Dec 2017
$31.49 M(+23.0%)
$31.49 M(+19.3%)
Sep 2017
-
$26.40 M(-7.6%)
Jun 2017
-
$28.56 M(+16.4%)
Mar 2017
-
$24.53 M(-4.2%)
Dec 2016
$25.60 M(+203.6%)
$25.60 M(+15.2%)
Sep 2016
-
$22.21 M(+22.0%)
Jun 2016
-
$18.20 M(+64.5%)
Mar 2016
-
$11.07 M(+31.3%)
Dec 2015
$8.43 M(-19.1%)
$8.43 M(-2.0%)
Sep 2015
-
$8.60 M(+38.9%)
Jun 2015
-
$6.19 M(-7.7%)
Mar 2015
-
$6.71 M(-35.6%)
Dec 2014
$10.42 M(+297.9%)
$10.42 M
Dec 2013
$2.62 M
-

FAQ

  • What is Collegium Pharmaceutical annual total current liabilities?
  • What is the all time high annual current liabilities for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical annual current liabilities year-on-year change?
  • What is Collegium Pharmaceutical quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical quarterly current liabilities year-on-year change?

What is Collegium Pharmaceutical annual total current liabilities?

The current annual current liabilities of COLL is $457.92 M

What is the all time high annual current liabilities for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high annual total current liabilities is $457.92 M

What is Collegium Pharmaceutical annual current liabilities year-on-year change?

Over the past year, COLL annual total current liabilities has changed by +$24.19 M (+5.58%)

What is Collegium Pharmaceutical quarterly total current liabilities?

The current quarterly current liabilities of COLL is $459.43 M

What is the all time high quarterly current liabilities for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high quarterly total current liabilities is $464.61 M

What is Collegium Pharmaceutical quarterly current liabilities year-on-year change?

Over the past year, COLL quarterly total current liabilities has changed by -$5.19 M (-1.12%)